2018 Regional RNDS
October 27 @ 8:00 am, EDT - 6:00 pm, EDT
An education and advocacy conference for families, caregivers and individuals diagnosed with Acute Disseminated Encephalomyelitis (ADEM), MOG Antibody-Associated Disease, Neuromyelitis Optica Spectrum Disorder (NMOSD), Optic Neuritis (ON), and Transverse Myelitis (including the subtype Acute Flaccid Myelitis)
Welcome to the 2018 Regional Rare Neuro-Immune Disorders Symposium for Acute Disseminated Encephalomyelitis (ADEM), MOG Antibody-Associated Disease, Neuromyelitis Optica Spectrum Disorder (NMOSD), Optic Neuritis (ON), and Transverse Myelitis (TM) (including the subtype Acute Flaccid Myelitis).
This conference hosted by The Transverse Myelitis Association (TMA) and Boston Children’s Hospital Center for Pain and The Brain is dedicated to the exchange of information regarding diagnosis, research and treatment strategies and to providing an opportunity to bring together the community of individuals diagnosed with these rare neuro-immune disorders, families, caregivers and the medical professionals who have interest and are specializing in these disorders.
This conference is open to all individuals diagnosed with rare neuro-immune disorders, their families and caregivers. Medical professionals interested in these disorders are also welcome to attend.
About The Center for Pain and the Brain
The Center for Pain and the Brain is a multidisciplinary team comprised of leading neurologists, physician-scientists, psychologists, physicists and neurobiologists. Founded and directed by David Borsook MD PhD, the Center spans Harvard Medical School, Boston Children’s Hospital, Massachusetts General Hospital and McLean Hospital. Our research focuses on the discovery of novel pain pathways, developing novel high-throughput methods for evaluating analgesics, and incorporating results from animal research into human applications. We are one of the few Centers that evaluates both pediatric and adult patient groups. Conducting neuroimaging studies in both acute and chronic pain cohorts as well as experimental pain in healthy volunteers, we seek to transform and improve the field of pain medicine.